MGWM
IDXX icon

Marks Group Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Marks Group Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Sell
3,620
-1,666
-32% -$934K 0.17% 137
2026
Q1 		$2.97M Sell
5,286
-2,686
-34% -$1.72M 0.29% 104
2025
Q4 		$5.39M Sell
7,972
-2,129
-21% -$1.45M 0.52% 75
2025
Q3 		$6.45M Sell
10,101
-1,839
-15% -$1.12M 0.6% 77
2025
Q2 		$6.4M Buy
11,940
+107
+0.9% +$51.2K 0.6% 74
2025
Q1 		$4.97M Buy
11,833
+824
+7% +$358K 0.48% 77
2024
Q4 		$4.55M Buy
11,009
+869
+9% +$381K 0.45% 83
2024
Q3 		$5.12M Buy
10,140
+601
+6% +$292K 0.49% 80
2024
Q2 		$4.65M Buy
9,539
+290
+3% +$146K 0.49% 77
2024
Q1 		$4.99M Buy
9,249
+337
+4% +$184K 0.52% 76
2023
Q4 		$4.95M Buy
8,912
+157
+2% +$73.7K 0.56% 75
2023
Q3 		$3.83M Sell
8,755
-57
-0.6% -$28.4K 0.47% 81
2023
Q2 		$4.43M Sell
8,812
-50
-0.6% -$24K 0.53% 79
2023
Q1 		$4.43M Sell
8,862
-81
-0.9% -$38.8K 0.57% 75
2022
Q4 		$3.65M Buy
8,943
+131
+1% +$50.9K 0.5% 81
2022
Q3 		$2.87M Buy
8,812
+494
+6% +$181K 0.44% 83
2022
Q2 		$2.92M Buy
8,318
+418
+5% +$170K 0.42% 83
2022
Q1 		$4.32M Buy
7,900
+600
+8% +$316K 0.54% 76
2021
Q4 		$4.83M Sell
7,300
-8
-0.1% -$5.02K 0.59% 68
2021
Q3 		$4.51M Sell
7,308
-309
-4% -$208K 0.61% 71
2021
Q2 		$4.83M Sell
7,617
-441
-5% -$244K 0.66% 72
2021
Q1 		$3.89M Buy
8,058
+37
+0.5% +$18.5K 0.58% 78
2020
Q4 		$4.01M Buy
8,021
+13
+0.2% +$5.82K 0.62% 73
2020
Q3 		$3.15M Buy
8,008
+63
+0.8% +$23.3K 0.57% 76
2020
Q2 		$2.63M Buy
7,945
+63
+0.8% +$18.2K 0.54% 84
2020
Q1 		$1.89M Buy
7,882
+338
+4% +$88.2K 0.49% 89
2019
Q4 		$1.97M Buy
+7,544
New +$1.99M 0.39% 103

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Marks Group Wealth Management's IDXX Position: Q2 2026 in Review

Marks Group Wealth Management reduced its Idexx Laboratories (IDXX) stake by 32% in Q2 2026, selling an estimated $934K and leaving 3,620 shares worth $1.91M. The position accounts for 0.17% of the portfolio, ranked #137.

Marks Group Wealth Management first reported a position in IDXX in Q4 2019 and has held it in 27 quarters since. The position peaked at $6.45M in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Marks Group Wealth Management held 3,620 shares of Idexx Laboratories worth $1.91M as of Q2 2026.
  • Marks Group Wealth Management sold 1,666 Idexx Laboratories shares in Q2 2026, an estimated $934K.
  • Idexx Laboratories made up 0.17% of Marks Group Wealth Management's portfolio in Q2 2026, its #137 holding.
  • Marks Group Wealth Management first reported a position in Idexx Laboratories in Q4 2019 and has held it in 27 quarters since.
  • Marks Group Wealth Management's Idexx Laboratories position peaked at $6.45M in Q3 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Marks Group Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.